CBP officers in Cincinnati seize shipment containing 30,000 Tramadol pills

LaFonda D. Sutton-Burke, Director of Field Operations at the Chicago Field Office
LaFonda D. Sutton-Burke, Director of Field Operations at the Chicago Field Office
0Comments

U.S. Customs and Border Protection (CBP) officers in Cincinnati intercepted a shipment containing 30,000 Tramadol tablets on December 4. The shipment, originating from Barbados and destined for St. Kitts-Nevis Island, was found to contain small boxes each holding 30 push pill tabs, totaling 30,000 tablets of the prescription drug.

Tramadol is classified as a Schedule IV substance under the Controlled Substances Act due to its potential for abuse. The seized tablets were 50mg each and have an estimated street value of $150,000.

LaFonda D. Sutton-Burke, Director of Field Operations at the Chicago Field Office, commented on the seizure: “Most people hear about CBP seizing narcotics shipments. However, shipments of illegal prescription pills are very dangerous too. These pills were not regulated by the FDA and can contain harmful chemicals that could be poisonous.”

Tramadol is used to treat moderate to moderately severe pain and acts similarly to opioid analgesics by altering how the brain perceives pain. It is often misused by narcotic addicts, chronic pain patients, and health professionals.

CBP advises buyers to ensure that any imported goods comply with state and federal regulations regarding admissibility requirements and clearance processes for e-commerce purchases.

CBP regularly screens international passengers and cargo arriving at U.S. ports of entry for narcotics, weapons, and other restricted items as part of its mission to enhance national safety and security through collaboration and innovation.



Related

Melanie Keller, Deputy Commissioner for Operations and Chief Operating Officer of FDA

How many companies in cities in Hamilton County received FDA inspections in Q1?

There were four companies in a city associated with Hamilton County that received four FDA inspections in the first quarter of 2026, according to the U.S. Food and Drug Administration.

Benjamin D. Moncarz Chief Financial Officer - FDA

FDA cites Givaudan Flavors Corporation in Cincinnati with 1 violation during Feb. 13 inspection

During a Feb. 13 inspection at Givaudan Flavors Corporation in Cincinnati, the FDA assessed food composition, standards, labeling, economic practices, and foodborne biological hazards, resulting in one citation.

Martin A. Makary, M.D. Commissioner of Food and Drugs of FDA

FDA conducts April 16 inspection at Cincinnati Eye Bank for Sight Restoration

On April 16, the FDA carried out an inspection focused on human cellular, tissue, and gene therapy operations at Cincinnati Eye Bank for Sight Restoration, LLC in Cincinnati, as reflected in the FDA’s publicly available data.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Cincy Reporter.